Jenni S Ilomaki (Jenni Ilomaki, Jenni Ilomäki, Jenni Ilomӓki)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 26

Top Venues

British journal of clinical pharmacology

Journal of diabetes

Clinical pharmacology and therapeutics

Pain medicine (Malden, Mass.)

Monash University Faculty of Pharmacy and Pharmaceutical Sciences

University of Eastern Finland (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Monash University Faculty of Pharmacy and Pharmaceutical Sciences Mar 01 2014

Australia

NHMRC Early Career Research Fellow :: Centre for Medicine Use and Safety

Education History

University of Eastern Finland

Finland

PHD

Publications

Kate E D Ziser, Adam C Livori MClinPharm, Jedidiah I Morton, Adaire E Prosser, Jenni S Ilomaki, Stephen J Wood
Acute kidney injury, renal impairment and renal failure associated with sodium glucose co-transporter-2 inhibitors in at-risk groups: A systematic review. British journal of clinical pharmacology 90 (7) (2024)
Kate E D Ziser, Stephen J Wood, George S Q Tan, Jedidiah I Morton, Jonathan Edward Shaw, J Simon Bell, Jenni S Ilomaki
The association between sodium glucose cotransporter-2 inhibitors vs dipeptidyl peptidase-4 inhibitors and renal outcomes in people discharged from hospital with type 2 diabetes: A population-based cohort study. Journal of diabetes 16 (4) (2024)
Kate E D Ziser, Stephen J Wood, George S Q Tan, Jedidiah I Morton, Jonathan Edward Shaw, J Simon Bell, Jenni S Ilomaki
The association between sodium glucose cotransporter-2 inhibitors vs dipeptidyl peptidase-4 inhibitors and renal outcomes in people discharged from hospital with type 2 diabetes: A population-based cohort study. Journal of diabetes 16 (4) (2024)
George S Q Tan, Jedidiah I Morton, Stephen J Wood, Jonathan Edward Shaw, Dianna J Magliano, Jenni S Ilomaki
SGLT-2 Inhibitor Use and Cause-Specific Hospitalization Rates: An Outcome-Wide Study to Identify Novel Associations of SGLT-2 Inhibitors. Clinical pharmacology and therapeutics (2024)
Kate E D Ziser, Adam C Livori MClinPharm, Jedidiah I Morton, Adaire E Prosser, Jenni S Ilomaki, Stephen J Wood
Acute kidney injury, renal impairment and renal failure associated with sodium glucose co-transporter-2 inhibitors in at-risk groups: A systematic review. British journal of clinical pharmacology 90 (7) (2024)
Kate E D Ziser, Adam C Livori MClinPharm, Jedidiah I Morton, Adaire E Prosser, Jenni S Ilomaki, Stephen J Wood
Acute kidney injury, renal impairment and renal failure associated with sodium glucose co-transporter-2 inhibitors in at-risk groups: A systematic review. British journal of clinical pharmacology (2024)
Kate E D Ziser, Stephen J Wood, George S Q Tan, Jedidiah I Morton, Jonathan Edward Shaw, J Simon Bell, Jenni S Ilomaki
The association between sodium glucose cotransporter-2 inhibitors vs dipeptidyl peptidase-4 inhibitors and renal outcomes in people discharged from hospital with type 2 diabetes: A population-based cohort study. Journal of diabetes 16 (4) (2024)
George S Q Tan, Jedidiah I Morton, Stephen J Wood, Jonathan Edward Shaw, Dianna J Magliano, Jenni S Ilomaki
SGLT-2 Inhibitor Use and Cause-Specific Hospitalization Rates: An Outcome-Wide Study to Identify Novel Associations of SGLT-2 Inhibitors. Clinical pharmacology and therapeutics 115 (6) (2024)
Monica Jung, Ting Xia, Jenni S Ilomaki, Christopher Pearce, Suzanne Nielsen
Trajectories of prescription opioid tapering in patients with chronic non-cancer pain: a retrospective cohort study, 2015-2020. Pain medicine (Malden, Mass.) 25 (4) (2024)
Monica Jung, Ting Xia, Jenni S Ilomaki, Christopher Pearce, Suzanne Nielsen
Trajectories of prescription opioid tapering in patients with chronic non-cancer pain: a retrospective cohort study, 2015-2020. Pain medicine (Malden, Mass.) 25 (4) (2024)
George S Q Tan, Jedidiah I Morton, Stephen J Wood, Jonathan Edward Shaw, Dianna J Magliano, Jenni S Ilomaki
SGLT-2 Inhibitor Use and Cause-Specific Hospitalization Rates: An Outcome-Wide Study to Identify Novel Associations of SGLT-2 Inhibitors. Clinical pharmacology and therapeutics 115 (6) (2024)
Miriam T Y Leung, Justin P Turner, Clara Marquina, Jenni S Ilomaki, Tim Tran, J Simon Bell
Impact of oral bisphosphonate drug holiday on mortality following hip fracture: a population-based cohort study. The Journal of clinical endocrinology and metabolism (2024)
Kate E D Ziser, Stephen J Wood, George S Q Tan, Jedidiah I Morton, Jonathan Edward Shaw, J Simon Bell, Jenni S Ilomaki
The association between sodium glucose cotransporter-2 inhibitors vs dipeptidyl peptidase-4 inhibitors and renal outcomes in people discharged from hospital with type 2 diabetes: A population-based cohort study. Journal of diabetes 16 (4) (2024)
Miriam T Y Leung, Justin P Turner, Clara Marquina, Jenni S Ilomaki, Tim Tran, J Simon Bell
Impact of oral bisphosphonate drug holiday on mortality following hip fracture: a population-based cohort study. The Journal of clinical endocrinology and metabolism (2024)
Tamrat Befekadu Abebe, Jedidiah I Morton, Jenni S Ilomaki, Zanfina Ademi
Future burden of myocardial infarction in Australia: impact on health outcomes between 2019 and 2038. European heart journal. Quality of care & clinical outcomes (2023)
Daniel Hsiang-Te Tsai, J Simon Bell, Shahab Abtahi, Brenda N Baak, Marloes T Bazelier, Ruth Brauer, Adrienne Y L Chan, Esther W Chan, Haoqian Chen, Celine S L Chui, Sharon Cook, Stephen Crystal, Poonam Gandhi, Sirpa Hartikainen, Frederick K Ho, Shao-Ti Hsu, Jenni S Ilomaki, Ju Hwan Kim, Olaf H Klungel, Marjaana Koponen, Wallis C Y Lau, Kui Kai Lau, Terry Y S Lum, Hao Luo, Kenneth K C Man, Jill P Pell, Soko Setoguchi, Shih-Chieh Shao, Chin-Yao Shen, Ju Young Shin, Patrick C Souverein, Anna-Maija Tolppanen, Li Wei, Ian C K Wong, Edward Chia-Cheng Lai
Cross-Regional Data Initiative for the Assessment and Development of Treatment for Neurological and Mental Disorders. Clinical epidemiology 15 (2023)
Leonie J Picton, Johnson George, J Simon Bell, Jenni S Ilomaki
Diabetes treatment deintensification in Australians with dementia compared to the general population: A national cohort study. Journal of the American Geriatrics Society (2023)
Daniel Hsiang-Te Tsai, J Simon Bell, Shahab Abtahi, Brenda N Baak, Marloes T Bazelier, Ruth Brauer, Adrienne Y L Chan, Esther W Chan, Haoqian Chen, Celine S L Chui, Sharon Cook, Stephen Crystal, Poonam Gandhi, Sirpa Hartikainen, Frederick K Ho, Shao-Ti Hsu, Jenni S Ilomaki, Ju Hwan Kim, Olaf H Klungel, Marjaana Koponen, Wallis C Y Lau, Kui Kai Lau, Terry Y S Lum, Hao Luo, Kenneth K C Man, Jill P Pell, Soko Setoguchi, Shih-Chieh Shao, Chin-Yao Shen, Ju Young Shin, Patrick C Souverein, Anna-Maija Tolppanen, Li Wei, Ian C K Wong, Edward Chia-Cheng Lai
Cross-Regional Data Initiative for the Assessment and Development of Treatment for Neurological and Mental Disorders. Clinical epidemiology 15 (2023)
Louise Lord, David McKernon, Luke E Grzeskowiak, Suzanne Kirsa, Jenni S Ilomaki
Depression and anxiety prevalence in people with cystic fibrosis and their caregivers: a systematic review and meta-analysis. Social psychiatry and psychiatric epidemiology (2022)
Rukshar Kaizerali Gobarani, Jenni S Ilomaki, Stephen Wood, Michael John Abramson, Billie Bonevski, Johnson George
Characterising the use of varenicline: an analysis of the Australian dispensing claims data. Addiction (Abingdon, England) 117 (10) (2022)
Monica Jung, Dickson Lukose, Suzanne Nielsen, J Simon Bell, Geoffrey I Webb, Jenni S Ilomaki
COVID-19 restrictions and the incidence and prevalence of prescription opioid use in Australia - a nationwide study. British journal of clinical pharmacology (2022)
Jenni S Ilomaki, J Simon Bell, Adrienne Y L Chan, Anna-Maija Tolppanen, Hao Luo, Li Wei, Edward Chia-Cheng Lai, Ju-Young Shin, Giorgia De Paoli, Romin Pajouheshnia, Frederick K Ho, Lorenna Reynolds, Kui Kai Lau, Stephen Crystal, Wallis C Y Lau, Kenneth K C Man, Ruth Brauer, Esther W Chan, Chin-Yao Shen, Ju Hwan Kim, Terry Y S Lum, Sirpa Hartikainen, Marjaana Koponen, Evelien Rooke, Marloes Bazelier, Olaf Klungel, Soko Setoguchi, Jill P Pell, Sharon Cook, Ian C K Wong
Application of Healthcare 'Big Data' in CNS Drug Research: The Example of the Neurological and mental health Global Epidemiology Network (NeuroGEN). CNS drugs 34 (9) (2021)
Jedidiah I Morton, Jenni S Ilomaki, Dianna J Magliano, Jonathan Edward Shaw
The association of socioeconomic disadvantage and remoteness with receipt of type 2 diabetes medications in Australia: a nationwide registry study. Diabetologia 64 (2) (2020)
Laura Fanning, Ian Chi Kei Ck Wong, Xue Li, Esther Wai Yin Chan, Pajaree Mongkhon, Kenneth Keng Cheung Man, Li Wei, Wai K Leung, Peteris Darzins, J Simon Bell, Jenni S Ilomaki, Wallis C Y Lau
Gastrointestinal bleeding risk with rivaroxaban vs aspirin in atrial fibrillation: A multinational study. Pharmacoepidemiology and drug safety 29 (12) (2020)
Esa Y H Chen, J Simon Bell, Jenni S Ilomaki, Claire Keen, Megan Corlis, Michelle Hogan, Jan Van Emden, Sarah N Hilmer, Janet Kathleen Sluggett
Medication Regimen Complexity In 8 Australian Residential Aged Care Facilities: Impact Of Age, Length Of Stay, Comorbidity, Frailty, And Dependence In Activities Of Daily Living. Clinical interventions in aging 14 (2019)
Karen Ho, Kris M Jamsen, J Simon Bell, Maarit Jaana Korhonen, Kevin P Mc Namara, Dianna J Magliano, Danny Liew, Taliesin E Ryan-Atwood, Jonathan E Shaw, Susan Luc, Jenni S Ilomaki
Demographic, clinical and lifestyle factors associated with high-intensity statin therapy in Australia: the AusDiab study. European journal of clinical pharmacology 74 (11) (2018)

Jenni S Ilomaki.css-eqlu8i{font-size:small;padding-left:4px;} (Jenni Ilomaki, Jenni Ilomäki, Jenni Ilomӓki)

Publication Activity (10 Years)

Top Topics

Top Venues

Jenni S Ilomaki (Jenni Ilomaki, Jenni Ilomäki, Jenni Ilomӓki)